Dr Reddy’s Laboratories Launch Tablets For Treatment Of Dementia In The US Market

Memantine hydrochloride tablets in the strengths of 5 mg and 10 mg are launched after getting the approval from the US Food and Drug Administration.

The generic Memantine hydrochloride tablets used for treatment of dementia of the Alzheimer's type have been launched by the pharmaceutical company Dr Reddy's Laboratories in the US market.

The company has launched the tablets in the strengths of 5 mg and 10 mg after getting the approval from the United States Food and Drug Administration (USFDA), said Dr Reddy's Laboratories in a filing to the Bombay Stock Exchange (BSE). The tablets are generic versions of Merz Pharma GmbH & Co KGaA's Namenda tablets, it added.

Ultherapy: US FDA Cleared Non-Invasive Facelift Technique Launched In India
The non-invasive cosmetic procedure uses focused ultrasound to stimulate the growth of new collagen deep within the skin, which lifts and tightens it over time.

"The Namenda (memantine HCl) tablets brand had US sales of approximately USD 1.4 billion MAT for the most recent twelve months ending in May 2015, according to IMS Health," said Dr Reddy's Laboratories.

The company's tablets in the 5 mg strength are available in the bottle count size of 60 and and 10 mg strength tablets are available in bottle count sizes of 60 and 500, it added. Shares of Dr Reddy's Laboratories today closed at Rs 3,758.75 per scrip on the BSE, up 0.44 percent from its previous close.

Source-PTI

Regulatory Authorities In The US Ban Drug Imports From Emcure Pharmaceuticals Ltd, India
The US Food and Drug Administration has barred imports from Emcure's Hinjewadi plant after an inspection showed manufacturing quality standards not met.

Mumbai- Based Drug Firm Recalls Over 160,000 Cartons of Drugs from the US Market
Recalls have been classified as 'Class-II' by the FDA because using or exposure to the drugs may have caused adverse health consequences in certain individuals

FDA Approves Nevro�s Senza Spinal Cord Stimulation System Delivering HF10 Therapy
The Senza spinal cord stimulation system’s HF10 therapy can help in managing chronic intractable pain of the trunk and limbs, lower back pain and leg pain.